What is a side effect of vasopressin?

A. "This drug should make me feel full.": Pioglitazone is a thiazolidinedione used to improve insulin sensitivity in type 2 diabetes. It does not act as an appetite suppressant, so expecting a feeling of fullness reflects a misunderstanding of its mechanism.

B. "This drug may cause flatulence.": While some medications for diabetes, such as alpha-glucosidase inhibitors, can cause flatulence, pioglitazone does not commonly produce this side effect. Expecting gas is not accurate for this drug.

C. "This drug can damage my liver.": Pioglitazone carries a risk of hepatotoxicity, so clients should be aware of signs of liver injury (e.g., jaundice, dark urine, fatigue). This statement demonstrates understanding of a key safety concern associated with the medication.

D. "This drug may cause weight loss.": Pioglitazone is more commonly associated with weight gain due to fluid retention rather than weight loss. Believing it promotes weight loss indicates a misconception about the drug’s effects.

A. Identify the client using two identifiers: Client identification is a critical safety step prior to medication administration, not after the insulin has already been given. Performing this step post-administration does not enhance immediate safety or therapeutic monitoring.

B. Verify the insulin dose with another nurse: Dose verification is an essential safety measure before administration, especially with high-alert medications like insulin. After administration, verifying the dose again does not prevent adverse events that could occur from an incorrect dose already given.

C. Gently roll the vial between hands to mix: Mixing the insulin by rolling the vial is performed prior to drawing up the medication to ensure uniform concentration, not after injection. Post-administration rolling has no clinical benefit.

D. Continue to monitor the client for hypoglycemia: Monitoring for hypoglycemia is critical after administering rapid-acting insulin like lispro. Insulin lowers blood glucose quickly, and clients are at risk for symptoms such as sweating, shakiness, confusion, or seizures, making vigilant post-administration observation essential.